3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Carcinoma, Basal Cell
4
Melanoma
2
Margins of Excision
2
Barrett Esophagus
2
Urologic Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Skin Lesion
1
Prostatic Neoplasms
1
Pancreatic Cyst
1
Nevus, Pigmented
1
Nephrolithiasis
1
Multicystic renal dysplasia, bilateral
1
Lung Neoplasms
1
Lung Diseases
1
Hematuria
1
Esophageal Neoplasms
1
Carcinoma, Squamous Cell
1
Benign Neoplasm of Liver and/or Biliary Ducts
1
Adenocarcinoma
1
Interventions
Docetaxel
171
Radiotherapy
144
Magnetic Resonance Spectroscopy
142
Leuprolide
112
Prednisone
108
enzalutamide
102
Radiosurgery
101
Abiraterone Acetate
94
Androgen Antagonists
91
Goserelin
83
bicalutamide
81
gallium 68 PSMA-11
70
Surveys and Questionnaires
63
apalutamide
57
Specimen Handling
56
acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide
55
Radiation
47
Gonadotropin-Releasing Hormone
45
Standard of Care
44
Biopsy
44
Brachytherapy
42
Radiotherapy, Intensity-Modulated
40
Blood Specimen Collection
40
darolutamide
39
abiraterone
39
cabazitaxel
35
Exercise
35
Carboplatin
33
Pluvicto
32
Triptorelin Pamoate
31
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Prostatic Neoplasms
×
Microscopy, Confocal
×
Clear all
NCT07541911
2026-05-18
LaserSAFE
University College, London
Phase NA
Recruiting
693 enrolled